SCHEMBL27738677

SCHEMBL27738677

NS(=O)(=O)N1CNc2ccccc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.41
POLB P06746 2/20 0.41
MAPT P10636 1/20 0.41
BRPF1 P55201 1/20 0.40
MEN1 O00255 4/20 0.37
KMT2A Q03164 4/20 0.37
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
HSD17B10 Q99714 2/20 0.35
HSD17B3 P37058 1/20 0.34
GAA P10253 3/20 0.33
MAPK1 P28482 1/20 0.33
BRD4 O60885 1/20 0.31
CA12 O43570 1/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
CA9 Q16790 1/20 0.31
TDP1 Q9NUW8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20541090 0.82 AVPR1A (0.39) ALDH1A1POLBMAPTBRPF1MEN1
SCHEMBL27679412 0.81 ALDH1A1 (0.41) ALDH1A1POLBMAPTBRPF1MEN1
Hydrochloric Acid SCHEMBL27738674 0.80 ALDH1A1 (0.40) ALDH1A1POLBMAPTBRPF1MEN1
SCHEMBL4265285 0.74 BRPF1 (0.41) ALDH1A1POLBMAPTBRPF1MEN1
Hydrochloric Acid SCHEMBL29450350 0.72 BRPF1 (0.40) ALDH1A1POLBMAPTBRPF1MEN1
SCHEMBL9706559 0.70 CYP3A4 (0.33) ALDH1A1MAPTCYP3A4CYP2D6CYP2C9
SCHEMBL28174282 0.69 BRD4 (0.40) ALDH1A1MEN1KMT2AHSD17B10HSD17B3
Hydrochloric Acid SCHEMBL27811171 0.67 AVPR1A (0.41) ALDH1A1POLBMAPTBRPF1MEN1
SCHEMBL3421961 0.67 HSD17B3 (0.47) ALDH1A1BRPF1MEN1KMT2AHSD17B3
SCHEMBL31345695 0.67 HSD17B3 (0.47) ALDH1A1BRPF1MEN1KMT2AHSD17B3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101404987-A Use of sulfonamide derivatives for the treatment of disorders of the surrogate and nervous systems SMITHKLINE BEECHAM CORP (US) 2009-04-08 CN disclosed